Onconova Therapeutics

Onconova Therapeutics Onconova Therapeutics, Inc. (NASDAQ: ONTX) is a clinical-stage biopharmaceutical company focused on

Meena Arora (VP Global Medical Affairs & R&D) and Dr Victor Moyo (Chief Medical Officer) are pleased to be at the 25th E...
03/08/2024

Meena Arora (VP Global Medical Affairs & R&D) and Dr Victor Moyo (Chief Medical Officer) are pleased to be at the 25th European Congress on Gynaecological Oncology in Barcelona. They have found sessions informative as well as thought provoking and have had great discussions with experts in the field. If you would like to connect in Barcelona, please email us at info@onconova.us.

03/08/2024

Onconova Therapeutics’ Rigosertib Poster Selected For AACR 2024
https://investor.onconova.com/press-releases
Poster Title: Rigosertib promotes anti-tumor activity of cancer cells via CETSA revealed novel targets and activates NLRP3-dependent inflammatory responses (2033/16)
Session: Microenvironment, Immunity, and DNA Repair in Therapeutic Response (PO.ET05.02)
Date/Time: Monday, April 8 9:00a-12:30p PT

02/29/2024

Address

12 Penns Trail
Newtown, PA
18940

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Onconova Therapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram